SCHEMBL698749

SCHEMBL698749

CCOc1ccc(C(N)=O)c2cc3ccccc3cc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.51
ALDH1A1 P00352 1/20 0.51
GAA P10253 1/20 0.51
PARP10 Q53GL7 3/20 0.49
PARP15 Q460N3 2/20 0.49
MKNK1 Q9BUB5 1/20 0.49
MKNK2 Q9HBH9 1/20 0.49
MAPK1 P28482 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C19 P33261 1/20 0.46
IRAK4 Q9NWZ3 1/20 0.46
LMNA P02545 2/20 0.45
RAB9A P51151 1/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
NR1I2 O75469 1/20 0.44
CHRM2 P08172 1/20 0.44
ADRA2A P08913 1/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL698753 0.83 NQO1 (0.65) KDM4EALDH1A1GAAPARP10PARP15
SCHEMBL23458217 0.82 NQO1 (0.59) KDM4EALDH1A1CYP1A2CYP2C19LMNA
SCHEMBL29919618 0.82 NQO1 (0.59) KDM4EALDH1A1CYP1A2CYP2C19LMNA
SCHEMBL6838380 0.78 KDM4E (0.68) KDM4EALDH1A1PARP10PARP15MKNK1
Ethenzamide SCHEMBL25624 0.77 MAPT (0.68) KDM4EGAAMAPK1CYP3A4IRAK4
Ethenzamide SCHEMBL27612766 0.77 MAPT (0.68) KDM4EGAAMAPK1CYP3A4IRAK4
SCHEMBL8053281 0.77 KDM4E (0.49) KDM4EALDH1A1GAAPARP10PARP15
Ethenzamide SCHEMBL22163775 0.76 MAPT (0.66) KDM4EGAAMAPK1CYP3A4IRAK4
Ethenzamide SCHEMBL4379591 0.76 MAPT (0.66) KDM4EGAAMAPK1CYP3A4IRAK4
Ethenzamide SCHEMBL5401172 0.76 MAPT (0.66) KDM4EGAAMAPK1CYP3A4IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423202-B1 Triazine-based compound and ultraviolet absorber FUJIFILM CORP (JP) 2013-01-16 EP disclosed
US-20120053343-A1 TRIAZINE-BASED COMPOUND AND ULTRAVIOLET ABSORBER FUJIFILM CORPORATION (JP) 2012-03-01 US disclosed
EP-2423202-A1 Triazine-based compound and ultraviolet absorber Fujifilm Corporation (JP) 2012-02-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053343-A1 TRIAZINE-BASED COMPOUND AND ULTRAVIOLET ABSORBER H1-2, H1-0, CHRM1 KDM4E 1888/4885ALDH1A1 818/4885GAA 4169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.